Press Release Contact

Press release:
Tellus Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations for Neonatal Brain Injury Program TT-20
October 21, 2020, 07:53 GMT

For questions about this press release, please contact the person or organization listed below.

Jason Kralic
Tellus Therapeutics, Inc.
+1 919-491-4995
Visit us on social media:
LinkedIn